About Biomatters
Biomatters is a Healthcare company based in Auckland (New Zealand) founded in 2004, and was acquired by Graphpad in April 2019. Software solutions for omics analysis are developed and commercialized. The company was acqui-hired. Biomatters offers products and services including Geneious Prime, Geneious Biologics, and Luma. Its focus areas include Life Sciences, Genomics, Genome Informatics and Sequence Analysis.
Company details
Biomatters was founded in 2004 in Auckland, New Zealand, within the bioinformatics sector. Software tools for omics data handling are created and marketed by the company. The primary product, Geneious, targets next-generation sequencing researchers and molecular biologists. Capabilities encompass sequence alignment, assembly, phylogenetics, primer design, annotation, and data management for applications in genomics, microbiology, and synthetic biology. Operations focus on workflow automation for research in agriculture, evolution, and biofuels.
- Headquarters Auckland, New Zealand
- Stage Acquired
- SectorsHealthcare
- Website biomatters.com
- Social LinkedIn X
- Acquired by Graphpad (Apr 2019)
Products & Services of Biomatters
Biomatters offers a comprehensive portfolio of products and services, including Geneious Prime, Geneious Biologics, and Luma.
Comprehensive tools for molecular biology and sequence analysis.
Cloud-based platform for antibody screening and data visualization.
Software for graphing and statistical analysis in scientific research.
Investors in Biomatters
Biomatters has secured backing from 1 investor. Prominent investors backing the company include Graphpad.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Cloud-based data visualization and analysis tools are supplied to scientists. | 1989 | graphpad.com | San Diego, United States |
Investor details for Biomatters
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Biomatters
2 dated milestones of Biomatters across 15 years, from founding to its latest funding, stage changes and deals.
- Founded Biomatters is founded.
- Exit Acquired by Graphpad.
Web traffic of Biomatters
Websites that share an audience with Biomatters (biomatters.com).
Websites whose visitors overlap most with Biomatters. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| ocimumbio.com | 100% | View details | |||
| geneious.com | 99% | 105.5K | #380,023 | View details | |
| 454.com | 98% | View details | |||
| interactive-biosoftware.com | 97% | 1.7K | View details | ||
| accelrys.com | 80% | View details | |||
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 6 similar websites and full traffic analytics for Biomatters
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 6 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Biomatters
Complete news archive for Biomatters
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Biomatters
Biomatters was founded in 2004.
Biomatters is headquartered in Auckland, New Zealand.
Biomatters was founded in 2004 in Auckland, New Zealand, within the bioinformatics sector. Software tools for omics data handling are created and marketed by the company. The primary product, Geneious, targets next-generation sequencing researchers and molecular biologists. Capabilities encompass sequence alignment, assembly, phylogenetics, primer design, annotation, and data management for applications in genomics, microbiology, and synthetic biology. Operations focus on workflow automation for research in agriculture, evolution, and biofuels.
Biomatters offers Geneious Prime, Geneious Biologics, and Luma.
Biomatters has 1 investor. Key investors include Graphpad.
Yes. Biomatters was acquired by Graphpad in April 2019.